Rigel Pharmaceuticals
RIGL
#6718
Rank
A$0.74 B
Marketcap
$42.39
Share price
0.70%
Change (1 day)
238.12%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$0.24 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's total liabilities are A$0.24 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Rigel Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.21 B-1.49%
2022-12-31A$0.21 B15.05%
2021-12-31A$0.18 B90.25%
2020-12-31A$99.29 M-25.85%
2019-12-31A$0.13 B222.71%
2018-12-31A$41.49 M75.44%
2017-12-31A$23.65 M-26.22%
2016-12-31A$32.05 M-42.15%
2015-12-31A$55.41 M75.16%
2014-12-31A$31.63 M58.46%
2013-12-31A$19.96 M-0.96%
2012-12-31A$20.15 M-1.38%
2011-12-31A$20.43 M0.96%
2010-12-31A$20.24 M-41.1%
2009-12-31A$34.37 M-38.91%
2008-12-31A$56.26 M46.36%
2007-12-31A$38.43 M16.5%
2006-12-31A$32.99 M-38.22%
2005-12-31A$53.4 M55.84%
2004-12-31A$34.27 M63.81%
2003-12-31A$20.92 M-37.64%
2002-12-31A$33.54 M-2.2%
2001-12-31A$34.3 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.10 B-56.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$100.12 B 40,792.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$128.91 B 52,549.66%๐Ÿ‡บ๐Ÿ‡ธ USA